Serum GFAP and UCHL1: Evaluation of Their Predictive Value for SAH

计划入组 144 人 · 首次发布于 2024 年 9 月 3 日

Effect of Controlled Hypotension on GFAP and Cognition in Rhinoplasty

计划入组 40 人 · 首次发布于 2026 年 7 月 13 日

Impact of Exercise Training on Serum Glial Fibrillary Acidic Protein (GFAP), Brain Volumetry, and Functional Outcomes in Multiple Sclerosis

计划入组 30 人 · 首次发布于 2026 年 4 月 13 日

Fibroblast growth factor-1

Recombinant human acidic fibroblast growth factor fusion protein

glial progenitor cell therapy

Protein Sciences Corporation

United States

Statens Serum Institut

Denmark

SERUM INSTITUTE OF INDIA PRIVATE LIMITED

India

Biomarkers sNfL and sGFAP Predict Disability Worsening in Multiple Sclerosis

Phase 2 Trial of Oral Fasudil for ALS Completes High-Dose Patient Recruitment

Rituximab Outperforms Cladribine in Real-World Multiple Sclerosis Study